학술논문

Structural signature of sporadic Creutzfeldt–Jakob disease
Document Type
article
Source
European Journal of Neurology. 26(8)
Subject
Biomedical and Clinical Sciences
Neurosciences
Clinical Sciences
Clinical Research
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Rare Diseases
Dementia
Brain Disorders
Transmissible Spongiform Encephalopathy (TSE)
Infectious Diseases
Alzheimer's Disease
Acquired Cognitive Impairment
Biomedical Imaging
Aging
Neurodegenerative
Aetiology
2.1 Biological and endogenous factors
Neurological
Aged
Brain
Creutzfeldt-Jakob Syndrome
Cross-Sectional Studies
Diffusion Magnetic Resonance Imaging
Female
Humans
Male
Middle Aged
Retrospective Studies
tau Proteins
biomarker
cortical signature
cortical thickness
Creutzfeldt-Jakob disease
magnetic resonance imaging
neurodegenerative disorders
prion diseases
rapidly progressive dementia
Neurology & Neurosurgery
Clinical sciences
Language
Abstract
Background and purposeSporadic Creutzfeldt-Jakob disease (sCJD) is a rapidly progressive neurodegenerative disease caused by an abnormal isoform of the human prion protein. Structural magnetic resonance imaging in patients with pathologically confirmed sCJD was compared with cognitively normal individuals to identify a cortical thickness signature of sCJD.MethodsThis retrospective cross-sectional study compared patients with autopsy-confirmed sCJD with dementia (n = 11) with age- and sex-matched cognitively normal individuals (n = 22). We identified regions of interest (ROIs) in which cortical thickness was most affected by sCJD. Within patients with sCJD, the relationship between ROI cortical thickness and clinical measures (disease duration, cerebrospinal fluid tau and diffusion-weighted imaging abnormalities) was evaluated.ResultsCompared with cognitively normal individuals, patients with sCJD had significantly reduced cortical thickness in multiple ROIs, including the fusiform gyrus, precentral gyrus, precuneus and superior temporal gyrus bilaterally; the caudal middle frontal gyrus, superior frontal gyrus, postcentral gyrus, inferior temporal gyrus and transverse temporal gyrus in the left hemisphere; and the superior parietal lobule in the right hemisphere. Only one patient with sCJD had co-pathology consistent with Alzheimer's disease. Reduced cortical thickness did not correlate with disease duration, presence of diffusion restriction or elevated cerebrospinal fluid tau.ConclusionCortical signature changes in sCJD may reflect brain changes not captured by standard clinical measures. This information may be used with clinical measures to inform the progression of sCJD and patterns of prion protein spread throughout the brain. These results may have implications for prediction of symptomatic progression and plausibly for development of therapeutic strategies.